id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0177-0005,FDA,FDA-2010-P-0177,"FDA/CDER to EAS Consulting Group, LLC - Response Letter",Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2013-08-11T01:38:43Z,,0,0,0900006480bb63c8
FDA-2010-P-0177-0004,FDA,FDA-2010-P-0177,Determination That AUGMENTIN ‘125’ (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium) Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,Notice,N-Notice,2010-12-08T05:00:00Z,2010,12,2010-12-08T05:00:00Z,,2010-12-08T16:13:47Z,2010-30622,0,0,0900006480bb20d9
FDA-2010-P-0177-0003,FDA,FDA-2010-P-0177,"Intermin Respponse to EAS Consulting Group, LLC",Other,LET-Letter,2010-09-27T04:00:00Z,2010,9,2010-09-27T04:00:00Z,,2013-08-11T03:10:55Z,,0,0,0900006480b61689
FDA-2010-P-0177-0002,FDA,FDA-2010-P-0177,Acknowledgement Letter to Aurobindo Pharmaceuticals Limited (EAS Consulting Group),Other,ACK-Acknowledgement Letter,2010-03-31T04:00:00Z,2010,3,2010-03-31T04:00:00Z,,2013-08-11T03:07:38Z,,0,0,0900006480acb72d
FDA-2010-P-0177-0001,FDA,FDA-2010-P-0177,Aurobindo Pharmaceuticals Limited (EAS Consulting Group) - Citizen Petition,Other,CP-Citizen Petition,2010-03-31T04:00:00Z,2010,3,2010-03-31T04:00:00Z,,2013-07-27T23:13:41Z,,0,0,0900006480acb70f